TY - JOUR
T1 - Post-translational loss of renal trpv5 calcium channel expression, Ca 2+ wasting, and bone loss in experimental colitis
AU - Radhakrishnan, Vijayababu M.
AU - Ramalingam, Rajalakshmy
AU - Larmonier, Claire B.
AU - Thurston, Robert D.
AU - Laubitz, Daniel
AU - Midura-Kiela, Monica T.
AU - McFadden, Rita Marie T.
AU - Kuro-O, Makoto
AU - Kiela, Pawel R.
AU - Ghishan, Fayez K.
N1 - Funding Information:
The authors thank Dr George Tsaprailis, PhD, for his valuable comments and suggestions during preparation and setting up for mass spectrometry analysis. The authors also would like to thank Pawel Kojs, Christy Harrison, and Dr Arash Sabetisoofyani for their technical assistance. The authors would like to acknowledge the help of Douglas W. Cromey (for assistance with confocal imaging), the Arizona Cancer Center/Arizona Research Laboratories (AZCC/ARL)-Division of Biotechnology Cytometry Core Facility, and the Cancer Center support grant (CCSG-CA 023074).
Funding Information:
Funding Supported by the National Institutes of Health ( 5R37DK033209 to F.K.G.). For mass spectrometry analysis, this study was supported by a National Institute of Environmental Health Sciences (NIEHS) grant ( ES06694 ) to the Southwest Environmental Health Sciences Center (SWEHSC), a National Institutes of Health/National Cancer Institute grant ( CA023074 ) to the Arizona Cancer Center (AZCC), and by the BIO5 Institute of the University of Arizona.
PY - 2013/9
Y1 - 2013/9
N2 - Background & Aims Dysregulated Ca2+ homeostasis likely contributes to the etiology of inflammatory bowel disease-associated loss of bone mineral density. Experimental colitis leads to decreased expression of Klotho, a protein that supports renal Ca2+ reabsorption by stabilizing the transient receptor potential vanilloid 5 (TRPV5) channel on the apical membrane of distal tubule epithelial cells. Methods Colitis was induced in mice via administration of 2,4,6-trinitrobenzenesulfonic acid (TNBS) or transfer of CD4+interleukin-10-/- and CD4+, CD45RBhi T cells. We investigated changes in bone metabolism, renal processing of Ca2+, and expression of TRPV5. Results Mice with colitis had normal serum levels of Ca2+ and parathormone. Computed tomography analysis showed a decreased density of cortical and trabecular bone, and there was biochemical evidence for reduced bone formation and increased bone resorption. Increased fractional urinary excretion of Ca2+ was accompanied by reduced levels of TRPV5 protein in distal convoluted tubules, with a concomitant increase in TRPV5 sialylation. In mouse renal intermedullary collecting duct epithelial (mIMCD3) cells transduced with TRPV5 adenovirus, the inflammatory cytokines tumor necrosis factor, interferon-γ, and interleukin-1β reduced levels of TRPV5 on the cell surface, leading to its degradation. Cytomix induced interaction between TRPV5 and UBR4 (Ubiquitin recoginition 4), an E3 ubiquitin ligase; knockdown of UBR4 with small interfering RNAs prevented cytomix-induced degradation of TRPV5. The effects of cytokines on TRPV5 were not observed in cells stably transfected with membrane-bound Klotho; TRPV5 expression was preserved when colitis was induced with TNBS in transgenic mice that overexpressed Klotho or in mice with T-cell transfer colitis injected with soluble recombinant Klotho. Conclusions After induction of colitis in mice via TNBS administration or T-cell transfer, tumor necrosis factor and interferon-γ reduced the expression and activity of Klotho, which otherwise would protect TRPV5 from hypersialylation and cytokine-induced TRPV5 endocytosis, UBR4-dependent ubiquitination, degradation, and urinary wasting of Ca2+.
AB - Background & Aims Dysregulated Ca2+ homeostasis likely contributes to the etiology of inflammatory bowel disease-associated loss of bone mineral density. Experimental colitis leads to decreased expression of Klotho, a protein that supports renal Ca2+ reabsorption by stabilizing the transient receptor potential vanilloid 5 (TRPV5) channel on the apical membrane of distal tubule epithelial cells. Methods Colitis was induced in mice via administration of 2,4,6-trinitrobenzenesulfonic acid (TNBS) or transfer of CD4+interleukin-10-/- and CD4+, CD45RBhi T cells. We investigated changes in bone metabolism, renal processing of Ca2+, and expression of TRPV5. Results Mice with colitis had normal serum levels of Ca2+ and parathormone. Computed tomography analysis showed a decreased density of cortical and trabecular bone, and there was biochemical evidence for reduced bone formation and increased bone resorption. Increased fractional urinary excretion of Ca2+ was accompanied by reduced levels of TRPV5 protein in distal convoluted tubules, with a concomitant increase in TRPV5 sialylation. In mouse renal intermedullary collecting duct epithelial (mIMCD3) cells transduced with TRPV5 adenovirus, the inflammatory cytokines tumor necrosis factor, interferon-γ, and interleukin-1β reduced levels of TRPV5 on the cell surface, leading to its degradation. Cytomix induced interaction between TRPV5 and UBR4 (Ubiquitin recoginition 4), an E3 ubiquitin ligase; knockdown of UBR4 with small interfering RNAs prevented cytomix-induced degradation of TRPV5. The effects of cytokines on TRPV5 were not observed in cells stably transfected with membrane-bound Klotho; TRPV5 expression was preserved when colitis was induced with TNBS in transgenic mice that overexpressed Klotho or in mice with T-cell transfer colitis injected with soluble recombinant Klotho. Conclusions After induction of colitis in mice via TNBS administration or T-cell transfer, tumor necrosis factor and interferon-γ reduced the expression and activity of Klotho, which otherwise would protect TRPV5 from hypersialylation and cytokine-induced TRPV5 endocytosis, UBR4-dependent ubiquitination, degradation, and urinary wasting of Ca2+.
KW - Mouse Model
KW - Osteoporosis
KW - UC
KW - Ulcerative Colitis
UR - http://www.scopus.com/inward/record.url?scp=84883151603&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883151603&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2013.06.002
DO - 10.1053/j.gastro.2013.06.002
M3 - Article
C2 - 23747339
AN - SCOPUS:84883151603
SN - 0016-5085
VL - 145
SP - 613
EP - 624
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -